CD39/NTPDase-1 activity and expression in normal leukocytes - Wikidata - wikimedia - TriplyDB

CD39/NTPDase-1 activity and expression in normal leukocytes

CD39/NTPDase-1 activity and expression in normal leukocytes

http://www.wikidata.org/entity/Q36479951

about

CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation.High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population Purinergic regulation of neutrophil chemotaxis.Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection.NTPDase1 governs P2X7-dependent functions in murine macrophages Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection Effect of Uncaria tomentosa extract on purinergic enzyme activities in lymphocytes of rats submitted to experimental adjuvant arthritis model.Characteristic expression of MSX1, MSX2, TBX2 and ENTPD1 in dental pulp cells Involvement of purinergic signaling on nitric oxide production by neutrophils stimulated with Trichomonas vaginalis.The UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils.CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way Development of Type 2, But Not Type 1, Leprosy Reactions is Associated with a Severe Reduction of Circulating and In situ Regulatory T-Cells CD39 and CD73 in immunity and inflammation.Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease.Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39+/CD73+ Murine Monocytes Modulate Intestinal Inflammation via Induction of Regulatory T Cells.Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.ENTPD1/CD39 is a promising therapeutic target in oncology.CD73 and adenosine generation in the creation of regulatory microenvironments.CD39: Interface between vascular thrombosis and inflammation.Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization.Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.Genetic variants regulating immune cell levels in health and disease.Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.High expression of CD39 in gastric cancer reduces patient outcome following radical resection Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.Characterization of E-NTPDase (EC 3.6.1.5) activity in hepatic lymphocytes: A different activity profile from peripheral lymphocytes.Ectonucleotidase CD39 expression in regional metastases in head and neck cancer.Characterization of ectonucleoside triphosphate diphosphohydrolase (E-NTPDase; EC 3.6.1.5) activity in mouse peritoneal cavity cells.Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.Defective ATP breakdown activity related to an ENTPD1 gene mutation demonstrated using 31P NMR spectroscopy.Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients

P2860

Q26801436-E7871CDD-3D6A-4EBD-9492-62C84FAF242A Q33917557-2ACBCA13-09B8-4317-BE79-943BFEEF93B6 Q33931235-1B7813D8-B5E1-4550-808F-3B447DF558FF Q34425713-1F750483-0E86-4E2E-B43D-F82130C283D5 Q34542781-C427807E-EA44-4553-A19A-F99198D5A33E Q34610192-4DE92BFB-4B5C-4B75-95ED-F9400C5143A8 Q34711777-EF65B56A-C2F3-4410-9021-748413C86B2C Q35667893-60B5E549-B050-4100-8EDD-CB69C3021518 Q35690311-8F003CA4-EA23-48B1-8403-2A4B40943E17 Q35777596-2B5723EF-B8A6-4E3C-89CB-1B202A7B6187 Q36308957-44F83574-B759-44F1-95D9-602BCF65E0C1 Q36664487-842332BD-ACC6-4D95-92CD-F25BB6C3657C Q36725685-130945E3-48D0-4131-AF8A-8965796CB000 Q36775999-978A0687-9754-4A06-86CB-D0633F3336C0 Q36906658-72C25473-4D28-4EC0-AB73-EB52BB760D64 Q37153791-8E3135B3-0DFF-410D-9A63-AFE43F6BE0DD Q37377260-9F01FABF-1EE8-46A2-8524-2DAAAD600660 Q37635119-4E0EC8AA-8555-4BAB-95A3-E92D599E38C6 Q37906358-A54E22D9-F1A8-4DFA-9F6C-5C8858C853B5 Q38023121-7903785F-FE5E-46D6-9C3C-E05545E9DB29 Q38063958-89D83B5E-15BD-4F4D-A3B8-8CFF972CA6D8 Q38212581-96A743D6-F735-4CF7-B98F-B2F211C33C76 Q38464138-B81C34F9-1135-4DCE-A623-0AD8EBED1889 Q39002543-D9303266-E85F-4F31-A6C9-D8E429C68D7F Q39601001-E0593B78-D987-4A5E-AB11-DE8EA673594B Q41229283-4DBECC69-EA24-4C99-85AF-EE8D164B690B Q41849280-F9F56E90-2072-48E1-BE18-342FB4BD47AC Q42109236-17418CB0-E2E3-4991-91D9-68EC1BDF2AE0 Q43140401-B71A011F-A31A-4DA4-9B03-C06F711A4B66 Q45362664-4E1C1DA3-4D64-4118-A52B-0D73462584D2 Q46255083-A72BFD55-C110-4701-B40E-1FC91747F5D7 Q47573193-45C76549-0A96-42D6-B345-066DF4CD8108 Q47856404-C7FE977F-F89D-4FC8-871F-696A8CDDC341 Q50273159-99DFBB3B-154C-47DE-B807-5442FBD64E68 Q50516122-9823E25A-0D80-42F3-9EE7-E6C327241321 Q56787000-380C73CB-916F-4570-9600-C12F50EDAA43

P2860

CD39/NTPDase-1 activity and expression in normal leukocytes

http://www.wikidata.org/entity/Q36479951

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

CD39/NTPDase-1 activity and expression in normal leukocytes

@ast

CD39/NTPDase-1 activity and expression in normal leukocytes

@en

type

label

CD39/NTPDase-1 activity and expression in normal leukocytes

@ast

CD39/NTPDase-1 activity and expression in normal leukocytes

@en

prefLabel

CD39/NTPDase-1 activity and expression in normal leukocytes

@ast

CD39/NTPDase-1 activity and expression in normal leukocytes

@en

P1433

Q36479951-AF6328D3-65FB-4835-8410-A73B39577F51

P1476

Q36479951-09A732DD-BEF1-4442-AF85-E67D20C77092

P2093

Q36479951-05E52775-E9BF-4251-8D23-311B2C3D3E1C

Q36479951-2964B48E-6F07-48C0-A613-F78BE0D50326

Q36479951-77DFC63A-D3D7-45CB-86BB-3EF0A4FF9D19

Q36479951-8B0CC400-3C99-425E-A98F-F67083E67DFB

Q36479951-B56B8C93-A468-4C41-9857-F8E4F941FB31

Q36479951-E280ECE9-3764-4E78-9945-055F65A60D32

Q36479951-FEA60DA7-B641-4480-B1C5-4C27275F2B89

P2860

Q36479951-168ED3E6-934D-4E53-897D-62EF666C33E8

Q36479951-1D836F13-396E-4651-8842-5BFF492377E4

Q36479951-24BE79BC-9D8E-4F1F-9269-E08E1EC70B9B

Q36479951-347CAFE3-D607-4421-B20B-1CCA35B99B0A

Q36479951-3CC10948-9514-4C14-8A78-17C93DA5E9F1

Q36479951-4AE48A25-FC67-491B-88BD-C52657B47271

Q36479951-5FE7AD6F-66F1-43EA-BB89-C69A566611B6

Q36479951-7CC6EA19-36F8-4613-AF0B-B14A1C5B418D

Q36479951-83AD9C79-479F-48AB-B365-12D4052ACC97

Q36479951-8C00B537-394E-4331-BD35-DF1AC60A430C

P304

Q36479951-45A3194A-5E46-4C19-9210-45A06FD82973

P31

Q36479951-A3C7F409-E3CC-43C3-974D-0B33F249021F

P356

Q36479951-DAD5EE17-72F9-4438-8A94-D5BEA4624CD0

P433

Q36479951-223B1660-8DFF-4EFB-ABA1-9A51FD394D61

P478

Q36479951-A080CFC3-9857-4760-B6B3-992A4EADC3A2

P577

Q36479951-3C1F4852-0C23-41E0-BDFF-D974CD107819

P5875

Q36479951-E843A3A2-1983-4E02-ADA4-43D36DA12000

P698

Q36479951-768529D8-C896-469C-9CE7-3218F33FA3BF

P932

Q36479951-F8E2E044-3B25-4458-8BF2-1F0ABBA44FDC

P356

J.THROMRES.2007.04.008

P1433

Thrombosis Research

P1476

CD39/NTPDase-1 activity and expression in normal leukocytes

@en

P2093

Aaron J Marcus

http://www.w3.org/2001/XMLSchema#string

E Dianne Pulte

http://www.w3.org/2001/XMLSchema#string

Joan H F Drosopoulos

http://www.w3.org/2001/XMLSchema#string

Jorge R Kizer

http://www.w3.org/2001/XMLSchema#string

Kim E Olson

http://www.w3.org/2001/XMLSchema#string

M Johan Broekman

http://www.w3.org/2001/XMLSchema#string

Naziba Islam

http://www.w3.org/2001/XMLSchema#string

P2860

The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization

Identification and characterization of CD39/vascular ATP diphosphohydrolase

CD39 modulates endothelial cell activation and apoptosis

Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection

Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain

The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.

Hypertension and the prothrombotic state.

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.

Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells.

Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.

P304

309-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.THROMRES.2007.04.008

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6280699

http://www.w3.org/2001/XMLSchema#string

P698

17555802

http://www.w3.org/2001/XMLSchema#string

P932

2255570

http://www.w3.org/2001/XMLSchema#string